CBD oil for anxiety and sleep in adults with generalized anxiety disorder
Part of Brain & nervous system, Mental health clinical trials.
This study tests a CBD oil product (called CannaRiver CBD Calm) to see if it helps reduce anxiety and improve sleep in adults diagnosed with generalized anxiety disorder. Participants take the oil twice a day for 8 weeks and complete questionnaires to track their symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have been diagnosed with generalized anxiety disorder by a doctor, and your symptoms have lasted at least 6 months.
- Your anxiety is moderate or severe (scoring at least 10 on a standard anxiety questionnaire at two checkpoints).
- If you take anxiety medication, your dose has been stable for at least 6 weeks, and you agree not to change it during the study.
- You are willing to take 0.5 mL of CBD oil by mouth every 12 hours for 8 weeks, complete online surveys, attend visits, and return any unused product.
- You have access to a smartphone or computer and can read Portuguese well enough to complete the study questionnaires.
- You agree to avoid all cannabis and CBD products for the entire study period, including at least 30 days before starting.
- You do not have certain other mental health conditions (like bipolar disorder, psychosis, or current severe depression) or recent substance use problems.
- You are not pregnant or planning to become pregnant, and you are willing to use approved birth control if needed.
- You do not have liver disease or other serious medical conditions, and you are not taking certain medications that could interact with CBD (like clobazam or valproate).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medicine (SEP-363856) for adults with generalized anxiety disorder to see if it reduces anxiety symptoms and is safe. It may help if other treatments haven't worked well.
This trial tests an investigational medication to see if it can reduce anxiety symptoms in adults with generalized anxiety disorder. Participants will receive the study drug and be monitored for safety and effectiveness.
This trial tests if adding cannabidiol (CBD) to a learning-based approach helps manage generalized anxiety disorder (GAD). It involves brain scans and taking CBD daily.
This study tests whether a cannabis-like drug can help people with higher-than-normal anxiety cope with a night of very little sleep. You will be asked to sleep only 4 hours on one occasion.
This study tests whether a pure CBD product (Epidiolex) can help older adults who use cannabis occasionally. It looks at how CBD affects people who already take medications for pain, sleep, or mood issues.
This early-phase study tests how cannabidiol (CBD) affects learning and anxiety. You may be able to join if you meet age and health requirements and have not used CBD or other cannabis recently.
Hear when a new Generalized Anxiety Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.